home - Center for heart failure research

16th Annual CHFR Symposium on Heart Failure

September 19-21 2018 at Holmenkollen Park Hotel, Oslo, Norway.

- Wednesday 19th: NORHEART Cardiac Café - the place to meet and be inspired! Lecture by Valentin Fuster, Editor in Chief of JACC, Icahn School of Mecdicine at Mount Sinai, New York, USA

- Thursday 20th: Day 1 of main program with Key Note Lecture and moderated poster sessions

- Friday 21st: Day 2 of main program with presentation by poster price winners

Click for more information and registration...

Confirmed speakers:

Valentin Fuster, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Nick L Mills, King's College London BHF Centre, The Rayne Institute, St Thomas' Hospital, London, UK
Satoshi Nakatani, Osaka University Graduate School of Medicine, Suita, Japan
Manuel Mayr, King's College, University of London, London, UK
Denise Hilfiker-Kleiner, Hannover Medical School, Hannover, Germany
Jagat Narula, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Thomas H Marwick, Baker Heart and Diabetes Institute, Melbourne, Australia
David A Kass, Institute for CardioScience, The Johns Hopkins Medical Institutions, Baltimore, MD, USA
Xander HT Wehrens, Baylor College of Medicine, Houston, Tx, USA
Brendan M Everett, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
Douglas L Mann, Washington University School of Medicine, St. Louis, MO, USA
Sanjay Sharma, St. Georges University of London, London, United Kingdom

Hot Topics: Young patients with lamin A/C mutations have high cardiac penetrance and frequent need for heart transplantation

Lamin A/C genotype-positive family members had a 9% annual incidence of a newly documented cardiac phenotype and 61% of cardiac penetrance during 4.4 years of follow-up. Heart transplantation was performed in 19% lamin A/C patients during 7.8 years of follow-up.

Hot Topics: Heart rate prediction of outcome in HF following MI

In patients with reduced systolic function and/or HF post-MI, higher heart rate predicts increased major cardiovascular events during the first year following MI in patients without AF. This association is markedly attenuated in subjects with AF.